Business Wire

Inteva Products Announces Executive Appointments in Europe

Jaa

Inteva Products, a leading global Tier One automotive supplier of engineered components and systems, is pleased to announce three recent appointments that strengthen its executive leadership team in Europe. Inteva has 15 manufacturing and R&D development sites in eight countries across Europe, serving automakers with roof systems, interior systems, closure systems, motors and electronics.

Andrés Keve, Executive Director, Roof Systems

Keve joined Inteva in June as the executive in charge of the global Roof Systems product line.

Keve was previously Vice President, Business Unit Aftermarket for Huf Hulsbeck & Furst GmbH & Co. KG, where he had also served as Vice President for Global Sales, reporting to the Board. Prior to those assignments, he had similar experiences at Lear Corporation GmbH, A.T. Kearney GmbH and United Technologies Automotive GmbH.

Keve earned his Master of Business Administration (MBA) at NIMBAS Graduate School of Management/University of Bradford, Netherlands and UK, and his Mechanical Engineering degree from Aachen University (RWTH). Andres is fluent in German, English, and Spanish.

Jose Teixeira, Executive Director of Quality

Teixeira joined Inteva on October 1. As Executive Director of Quality, he will lead Inteva’s efforts to execute and improve our global quality systems.

Teixeira brings to Inteva more than 25 years of global manufacturing leadership experience. Most recently, he served as Global Corporate Quality Director for Ficosa International. During his tenure with Ficosa, he also held positions as interim CEO, North Africa; COO, North America; General Manager, Berne, Ind. plant; and Plant Manager, Maia, Portugal. Prior to joining Ficosa, Teixeira was General Manager and Plant Manager at Simoldes Plasticos. He previously held positions with Fhest SGPS, Philips Consumer Electronics and Renault/Nissan.

Teixeira has a Master in Electronics and Telecommunications degree from the University of Aveiro, in Aveiro, Portugal, and a Master of Business Administration degree from the Institute of Science and Innovation in Mechanical and Industrial Engineering, Porto, Portugal. He is fluent in English, Spanish, French and Portuguese.

Patrick Stewart, Vice President, General Manager Europe

Stewart began this new assignment in June. Since Inteva’s founding in 2008 until this assignment, he had served as Inteva’s Vice President & Executive Director, Interior Systems, with global responsibility for the Interior Systems product line. Prior to 2008, Stewart held a wide variety of assignments at Delphi and other suppliers. Previous positions included Launch Manager; Manager, Global Product Engineering, Interior Systems; and Chief Engineer of Interior Systems & Cockpits.

Stewart earned a Bachelor of Science degree in Chemical Engineering from the University of Dayton (Ohio) and a Master of Science degree in Engineering Science from Rensselaer Polytechnical Institute in Troy, New York. He is a graduate of Delphi’s Lean College and has attended leadership training at the Center for Creative Leadership. Stewart is a Six Sigma Green Belt with extensive training in statistical quality and process control.

All three executives report directly to Lon Offenbacher, Inteva CEO & President; all are based in Dietzenbach, Germany.

About Inteva Products, LLC

Inteva Products, LLC is a leading global automotive supplier providing automakers with innovative, reliable, environmentally friendly products that enhance vehicle quality, safety and performance. Inteva has global resources for engineering, manufacturing and customer service for Closure Systems, Interior Systems, Motors and Electronics, and Roof Systems. Formed in 2008, the tier-one supplier is focused on achieving sustained global growth, providing excellent customer service and driving innovation. Inteva was founded on innovative solutions and the use of applied technology to drive value-based solutions. Inteva employs more than 15,000 people globally and is headquartered in Troy, Michigan USA.

For future company updates, please visit the Inteva Products website, or the company’s Facebook, LinkedIn and Twitter pages.

Contact information

Inteva Products
Karen Manardo
248-535-4825
kmanardo@intevaproducts.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar16.12.2017 01:13Tiedote

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 15:34Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 15:21Tiedote

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 14:38Tiedote

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 14:00Tiedote

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 12:00Tiedote

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme